research update

  • Research updates, June 30

    Research updates, June 30

    A recent imaging study in Sage Journals identified metabolic dysfunction in the brains of people with Long COVID who experience PEM. The study assessed 40 people with the disease from a Long COVID clinic with an advanced imaging technique that can detect various cancers and neurologic conditions.

  • Research updates, June 23

    Research updates, June 23

    A new study found that people with Long COVID were significantly more likely to experience cardiovascular disease after COVID-19. Published in Clinical Medicine Insights: Cardiology, researchers assessed a retrospective cohort of over 8,000 people who had a prior SARS-CoV-2 infection, discovering that Long COVID symptoms were associated with higher odds of cardiovascular disease, particularly angina…

  • Research updates, June 16

    Research updates, June 16

    Two recent studies have added more evidence that the diabetes drug metformin can reduce the risk of Long COVID.

  • Research updates, June 9

    Research updates, June 9

    A new study published in Alzheimer’s and Dementia found more evidence of alterations associated with Alzheimer’s disease in people with Long COVID. Notably, scientists identified a larger choroid plexus, a region of blood vessels in the brain, as well as reduced cerebral blood flow.

  • Research updates, June 2

    Research updates, June 2

    The COVID-19 antiviral ensitrelvir (Xocova), was recently approved by the Food and Drug Administration. The oral drug was approved as PEP, or post-exposure prophylaxis, meaning it is taken within 72 hours after coming in contact with someone who has COVID-19.

  • Research updates, May 26

    Research updates, May 26

    More research articles

  • Research updates, May 19

    Research updates, May 19

    More research updates

  • Research updates, May 12

    Research updates, May 12

  • Research updates, May 5

    Research updates, May 5

    A specific formula of probiotics and bacteria was found to improve fatigue and other symptoms in people with Long COVID. Researchers shared the abstract, which has not been published yet, at the Digestive Disease Week meeting in Chicago, Illinois.

  • Research updates, April 28

    Research updates, April 28

    The written memorials of over 500 people who had myalgic encephalomyelitis (ME) were analyzed in a new study in PLoS One. Researchers found themes of clinical neglect and broad institutional failure, among others.

get the latest long covid news

Processing…
Success! You're on the list.
SpotifyApple PodcastsPocketCastsAmazon MusiciHeartRadio